ASO Author Reflections: Multimodality Treatment in Esophageal Signet Ring Cell Adenocarcinoma

Ann Surg Oncol. 2019 Dec;26(Suppl 3):796-797. doi: 10.1245/s10434-019-07924-5. Epub 2019 Oct 21.

Authors

Sander J M van Hootegem¹, Bas P L Wijnhoven²

Affiliations

¹ Department of Surgery, Erasmus MC, University Medical Center, Rotterdam, The Netherlands. s.vanhootegem@erasmusmc.nl.
² Department of Surgery, Erasmus MC, University Medical Center, Rotterdam, The Netherlands.

No abstract available

MeSH terms

Carcinoma, Signet Ring Cell / pathology*
Carcinoma, Signet Ring Cell / therapy
Combined Modality Therapy
Esophageal Neoplasms / pathology*
Esophageal Neoplasms / therapy
Humans
Neoplasm Recurrence, Local / pathology*
Neoplasm Recurrence, Local / therapy
Prognosis
Survival Rate